Sign In
Buy ZBH
$84.98
+1.23 (+1.47%)
At Close: Jun 03, 2026
Zimmer (ZBH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
10:36am, Thursday, 06'th Feb 2025
Although the revenue and EPS for Zimmer (ZBH) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street
Zimmer Biomet forecasts 2025 profit below estimates
08:41am, Thursday, 06'th Feb 2025
Medical device maker Zimmer Biomet Holdings forecast full-year adjusted profit below Wall Street estimates on Thursday, as it anticipates a hit from a strong dollar.
Zimmer Biomet (ZBH) Surpasses Q4 Earnings and Revenue Estimates
08:41am, Thursday, 06'th Feb 2025
Zimmer Biomet (ZBH) came out with quarterly earnings of $2.31 per share, beating the Zacks Consensus Estimate of $2.30 per share. This compares to earnings of $2.20 per share a year ago.
Zimmer Biomet Announces Fourth Quarter and Full-Year 2024 Financial Results
06:30am, Thursday, 06'th Feb 2025
Fourth quarter net sales of $2.023 billion increased 4.3% and 4.9% on a constant currency1 basis Fourth quarter diluted earnings per share were $1.20; adjusted1 diluted earnings per share were $2.31 F
Unveiling Zimmer (ZBH) Q4 Outlook: Wall Street Estimates for Key Metrics
10:20am, Tuesday, 04'th Feb 2025
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Zimmer (ZBH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quar
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Paragon 28, Inc.
04:25pm, Friday, 31'st Jan 2025
NEW YORK , Jan. 31, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Paragon 28, Inc. (NYSE: FNA) and its board of directors concerning the proposed acquis
Zimmer Biomet Set to Report Q4 Earnings: What's in Store?
11:47am, Friday, 31'st Jan 2025
ZBH's Hips business is expected to have witnessed growth banking on its suite of navigation solutions in direct anterior stems and surgical impactors.
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Paragon 28,
Zimmer Biomet to buy Paragon 28 for $1.1 billion
06:11pm, Tuesday, 28'th Jan 2025
Zimmer Biomet said on Tuesday it would acquire medical device company Paragon 28 for about $1.1 billion.
Emerging Market Expansion Supports ZBH Stock Amid Macro Issues
11:36am, Tuesday, 21'st Jan 2025
Zimmer Biomet is witnessing strong market share gains within reconstructive Knees and Hips in key geographies despite macroeconomic challenges.
Should You Consider Retaining ZBH Stock in Your Portfolio Now?
07:33am, Tuesday, 14'th Jan 2025
Zimmer Biomet's robust efforts to expand the Knee business and a gradually stabilizing musculoskeletal market appear promising.
Zimmer Biomet: Back On Offense With Strong Cash Flow Outlook
05:25pm, Sunday, 05'th Jan 2025
Zimmer Biomet Holdings (ZBH) is expanding its product portfolio and improving cash flow, positioning it for long-term profitability and financial health. ZBH is undervalued compared to peers, with sig
ZBH Stock to Benefit From Global Expansion Despite Macro Issues
11:32am, Thursday, 26'th Dec 2024
Zimmer Biomet is witnessing strong market share gains within reconstructive Knees and Hips in key geographies despite macroeconomic challenges.
ZBH Stock Might Rise Following FDA Nod for OsseoFit
08:36am, Monday, 16'th Dec 2024
Zimmer Biomet's OsseoFit Stemless Shoulder System gets FDA 510(k) approval. The company expects to launch the system in the first quarter of 2025.
2 Robotic Surgery Stocks Challenging Intuitive Surgical's Lead
07:01am, Thursday, 12'th Dec 2024
Robotic surgery used to be fodder for science fiction movies. Not anymore.
